304 related articles for article (PubMed ID: 10807457)
1. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial.
Heeschen C; Hamm CW; Bruemmer J; Simoons ML
J Am Coll Cardiol; 2000 May; 35(6):1535-42. PubMed ID: 10807457
[TBL] [Abstract][Full Text] [Related]
2. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.
Hamm CW; Heeschen C; Goldmann B; Vahanian A; Adgey J; Miguel CM; Rutsch W; Berger J; Kootstra J; Simoons ML
N Engl J Med; 1999 May; 340(21):1623-9. PubMed ID: 10341274
[TBL] [Abstract][Full Text] [Related]
3. Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA.
Lenderink T; Boersma E; Heeschen C; Vahanian A; de Boer MJ; Umans V; van den Brand MJ; Hamm CW; Simoons ML;
Eur Heart J; 2003 Jan; 24(1):77-85. PubMed ID: 12559939
[TBL] [Abstract][Full Text] [Related]
4. Angiographic findings in patients with refractory unstable angina according to troponin T status.
Heeschen C; van Den Brand MJ; Hamm CW; Simoons ML
Circulation; 1999 Oct; 100(14):1509-14. PubMed ID: 10510053
[TBL] [Abstract][Full Text] [Related]
5. Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. EPIC Investigators. Evaluation of 7E3 in Preventing Ischemic Complications.
Lincoff AM; Califf RM; Anderson KM; Weisman HF; Aguirre FV; Kleiman NS; Harrington RA; Topol EJ
J Am Coll Cardiol; 1997 Jul; 30(1):149-56. PubMed ID: 9207636
[TBL] [Abstract][Full Text] [Related]
6. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris.
Rebuzzi AG; Quaranta G; Liuzzo G; Caligiuri G; Lanza GA; Gallimore JR; Grillo RL; Cianflone D; Biasucci LM; Maseri A
Am J Cardiol; 1998 Sep; 82(6):715-9. PubMed ID: 9761079
[TBL] [Abstract][Full Text] [Related]
7. Reduction of recurrent ischemia with abciximab during continuous ECG-ischemia monitoring in patients with unstable angina refractory to standard treatment (CAPTURE).
Klootwijk P; Meij S; Melkert R; Lenderink T; Simoons ML
Circulation; 1998 Oct; 98(14):1358-64. PubMed ID: 9760288
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of C-reactive protein and troponin T level in patients with unstable angina pectoris].
Tanaka H; Tsurumi Y; Kasanuki H
J Cardiol; 2006 Apr; 47(4):173-9. PubMed ID: 16637251
[TBL] [Abstract][Full Text] [Related]
9. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes.
Lenderink T; Heeschen C; Fichtlscherer S; Dimmeler S; Hamm CW; Zeiher AM; Simoons ML; Boersma E;
J Am Coll Cardiol; 2006 Jan; 47(2):307-11. PubMed ID: 16412852
[TBL] [Abstract][Full Text] [Related]
10. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study.
Lancet; 1997 May; 349(9063):1429-35. PubMed ID: 9164316
[TBL] [Abstract][Full Text] [Related]
11. Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial.
van den Brand M; Laarman GJ; Steg PG; De Scheerder I; Heyndrickx G; Beatt K; Kootstra J; Simoons ML
Eur Heart J; 1999 Nov; 20(21):1572-8. PubMed ID: 10529325
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.
Morrow DA; Rifai N; Antman EM; Weiner DL; McCabe CH; Cannon CP; Braunwald E
J Am Coll Cardiol; 1998 Jun; 31(7):1460-5. PubMed ID: 9626820
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group.
Simoons ML; de Boer MJ; van den Brand MJ; van Miltenburg AJ; Hoorntje JC; Heyndrickx GR; van der Wieken LR; de Bono D; Rutsch W; Schaible TF
Circulation; 1994 Feb; 89(2):596-603. PubMed ID: 7508826
[TBL] [Abstract][Full Text] [Related]
14. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
Lindahl B; Toss H; Siegbahn A; Venge P; Wallentin L
N Engl J Med; 2000 Oct; 343(16):1139-47. PubMed ID: 11036119
[TBL] [Abstract][Full Text] [Related]
15. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. EPIC investigators.
Lefkovits J; Ivanhoe RJ; Califf RM; Bergelson BA; Anderson KM; Stoner GL; Weisman HF; Topol EJ
Am J Cardiol; 1996 May; 77(12):1045-51. PubMed ID: 8644655
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet therapy in therapy-resistant unstable angina. A pilot study with REO PRO (c7E3).
van den Brand MJ; Simoons ML; de Boer MJ; van Miltenburg A; van der Wieken LR; de Feyter PJ
Eur Heart J; 1995 Nov; 16 Suppl L():36-42. PubMed ID: 8869017
[TBL] [Abstract][Full Text] [Related]
17. [Stratification of cardiac risk in unstable angina: value of troponin measurements].
Chérif A; Messaoudi H; Mourali S; Ezzar T; Boussaada R; Mechmèche R
Tunis Med; 2002 Oct; 80(10):581-3. PubMed ID: 12632750
[TBL] [Abstract][Full Text] [Related]
18. Incidence and determinants of myocardial infarction following percutaneous coronary interventions according to the revised Joint Task Force definition of troponin T elevation.
Alcock RF; Roy P; Adorini K; Lau GT; Kritharides L; Lowe HC; Brieger DB; Freedman SB
Int J Cardiol; 2010 Apr; 140(1):66-72. PubMed ID: 19131135
[TBL] [Abstract][Full Text] [Related]
19. Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) Trial.
Ottervanger JP; Armstrong P; Barnathan ES; Boersma E; Cooper JS; Ohman EM; James S; Topol E; Wallentin L; Simoons ML;
Circulation; 2003 Jan; 107(3):437-42. PubMed ID: 12551868
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of quantitative troponin T measurements in unstable angina/non-ST-segment elevation acute myocardial infarction treated early and predominantly with percutaneous coronary intervention.
Mueller C; Neumann FJ; Perruchoud AP; Zeller T; Buettner HJ
Am J Med; 2004 Dec; 117(12):897-902. PubMed ID: 15629727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
